01-01-1970 12:00 AM | Source: Reuters
India`s Stelis Biopharma to supply 200 million doses of Sputnik V vaccine
BENGALURU - Indian drugmaker Strides Pharma Science said on Friday its unit Stelis Biopharma has partnered with the Russian Direct Investment Fund to produce and supply at least 200 million doses of the Sptunik V COVID-19 vaccine.
Latest News
Buy ABB India Ltd For Target Rs.8,500 By Motilal Osw...
`The Sabarmati Report`: Vikrant Massey highlights fi...
Shraddha Kapoor, Varun Dhawan spotted in dazzling bl...
India aims for equity and balance when negotiating F...
Evening Roundup : A Daily Report on Bullion Energy &...
Mumbai: Actor Amitabh Bachchan greets fans outside h...
PM Narendra Modi receives traditional welcome in Rio...
Brazilian Vedic scholars chant `Vedic Mantras` to we...
Brazilian Vedic scholars to chant `Vedic Mantras` be...
Indian Diaspora excited, emotional and proud over PM...